ID24890A - Komposisi-komposisi insulin yang tidak dapat larut - Google Patents

Komposisi-komposisi insulin yang tidak dapat larut

Info

Publication number: ID24890A
Authority: ID; Indonesia
Prior art keywords: soluted; insulin compositions; insulin; compositions
Prior art date: 1997-10-24

Application number

IDW20000748A

Other languages

English (en)

Inventor

Mark Laurence Brader

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-24

Filing date

1998-10-22

Publication date

2000-08-31

1998-10-22 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2000-08-31 Publication of ID24890A publication Critical patent/ID24890A/id

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

IDW20000748A 1997-10-24 1998-10-22 Komposisi-komposisi insulin yang tidak dapat larut ID24890A (id)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6310497P	1997-10-24	1997-10-24
US8893098P	1998-06-11	1998-06-11

Publications (1)

Publication Number	Publication Date
ID24890A true ID24890A (id)	2000-08-31

Family

ID=26743043

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20000748A ID24890A (id)	1997-10-24	1998-10-22	Komposisi-komposisi insulin yang tidak dapat larut

Country Status (21)

Country	Link
US (3)	US6268335B1 (id)
EP (1)	EP1039920A4 (id)
JP (2)	JP2001521006A (id)
KR (1)	KR20010024556A (id)
CN (1)	CN1276731A (id)
AR (1)	AR020047A1 (id)
AU (2)	AU1111799A (id)
BR (1)	BR9813111A (id)
CA (2)	CA2306877A1 (id)
CO (1)	CO4970769A1 (id)
EA (1)	EA200000453A1 (id)
HR (1)	HRP20000236A2 (id)
HU (1)	HUP0004169A3 (id)
ID (1)	ID24890A (id)
IL (1)	IL134901A0 (id)
NO (1)	NO20002038L (id)
PE (1)	PE123799A1 (id)
PL (1)	PL340255A1 (id)
SV (1)	SV1998000125A (id)
TR (1)	TR200001050T2 (id)
WO (2)	WO1999021573A1 (id)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6444641B1 (en)	1997-10-24	2002-09-03	Eli Lilly Company	Fatty acid-acylated insulin analogs
US6531448B1 (en)	1997-12-23	2003-03-11	Eli Lilly And Company	Insoluble compositions for controlling blood glucose
US7169889B1 (en)	1999-06-19	2007-01-30	Biocon Limited	Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US20030054015A1 (en) *	2000-12-25	2003-03-20	Shinichiro Haze	Sympathetic-activating perfume composition
US7060675B2 (en) *	2001-02-15	2006-06-13	Nobex Corporation	Methods of treating diabetes mellitus
US6867183B2 (en)	2001-02-15	2005-03-15	Nobex Corporation	Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US20020155614A1 (en) *	2001-02-21	2002-10-24	Tomlinson Andrew J.	Peptide esterification
US7713932B2 (en)	2001-06-04	2010-05-11	Biocon Limited	Calcitonin drug-oligomer conjugates, and uses thereof
US6858580B2 (en)	2001-06-04	2005-02-22	Nobex Corporation	Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en)	2001-06-04	2004-12-28	Nobex Corporation	Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6828297B2 (en)	2001-06-04	2004-12-07	Nobex Corporation	Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en) *	2001-06-04	2004-12-07	Nobex Corporation	Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en)	2001-06-04	2004-03-30	Nobex Corporation	Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
EP1432430A4 (en) *	2001-08-28	2006-05-10	Lilly Co Eli	PREMIXTURES OF GLP-1 AND BASALINSULIN
US7030082B2 (en) *	2001-09-07	2006-04-18	Nobex Corporation	Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
US6770625B2 (en)	2001-09-07	2004-08-03	Nobex Corporation	Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US7166571B2 (en) *	2001-09-07	2007-01-23	Biocon Limited	Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en)	2001-09-07	2007-03-27	Biocon Limited	Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7312192B2 (en) *	2001-09-07	2007-12-25	Biocon Limited	Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6913903B2 (en)	2001-09-07	2005-07-05	Nobex Corporation	Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US20030095928A1 (en) *	2001-09-19	2003-05-22	Elan Pharma International Limited	Nanoparticulate insulin
AU2002346491A1 (en) *	2001-12-19	2003-07-09	Eli Lilly And Company	Crystalline compositions for controlling blood glucose
CZ2004710A3 (cs) *	2001-12-20	2005-02-16	Eli Lilly And Company	Inzulínová sloučenina s protrahovaným účinkem
AU2003236521A1 (en)	2002-06-13	2003-12-31	Nobex Corporation	Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
US20040038864A1 (en) *	2002-06-27	2004-02-26	Per Balschmidt	Use of dimethyl sulfone as isotonicity agent
US20060258561A1 (en) *	2003-03-13	2006-11-16	Novo Nordisk A/S	Novel NPH insulin preparations
WO2004080481A1 (en) *	2003-03-13	2004-09-23	Novo Nordisk A/S	Novel nph insulin preparations
US20050054818A1 (en) *	2003-07-02	2005-03-10	Brader Mark Laurence	Crystalline compositions for controlling blood glucose
DK1648933T3 (da) *	2003-07-25	2009-09-07	Conjuchem Biotechnologies Inc	Langvarige insulinderivater og fremgangsm der
CA2531988C (en)	2003-08-05	2016-06-28	Novo Nordisk A/S	Novel insulin derivatives
EP1692168B1 (en)	2003-12-03	2011-07-20	Novo Nordisk A/S	Single-chain insulin
RU2527893C2 (ru)	2004-07-19	2014-09-10	Биокон Лимитед	Инсулин-олигомерные конъюгаты, их препараты и применения
US8263551B2 (en)	2004-11-22	2012-09-11	Novo Nordisk A/S	Soluble, stable insulin-containing formulations with a protamine salt
EP1679065A1 (en) *	2005-01-07	2006-07-12	OctoPlus Sciences B.V.	Controlled release compositions for interferon based on PEGT/PBT block copolymers
JP2008533100A (ja) *	2005-03-18	2008-08-21	ノボノルディスクアクティーゼルスカブ	Ｐｅｇ化された単鎖インスリン
ES2371361T3 (es)	2005-12-28	2011-12-30	Novo Nordisk A/S	Composiciones que comprenden una insulina acilada y zinc y método de producción de dichas composiciones.
WO2007081824A2 (en) *	2006-01-06	2007-07-19	Case Western Reserve University	Fibrillation resistant proteins
WO2007121318A2 (en) *	2006-04-12	2007-10-25	Emisphere Technologies, Inc.	Formulations for delivering insulin
JP2009536670A (ja) *	2006-05-10	2009-10-15	スミスクライン・ビーチャム・コーポレイション	化合物の細胞浸透性を増加させるための組成物および方法
WO2007135118A1 (en) *	2006-05-24	2007-11-29	Novo Nordisk A/S	Soluble, stable insulin-containing formulations
CN101573133B (zh)	2006-07-31	2014-08-27	诺沃-诺迪斯克有限公司	Peg化延长的胰岛素
RU2524150C2 (ru)	2006-09-22	2014-07-27	Ново Нордиск А/С	Аналоги инсулина, устойчивые к протеазам
WO2008043033A2 (en)	2006-10-04	2008-04-10	Case Western Reserve University	Fibrillation-resistant insulin and insulin analogues
JP5496082B2 (ja)	2007-04-30	2014-05-21	ノボ・ノルデイスク・エー／エス	タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
JP5552046B2 (ja)	2007-06-13	2014-07-16	ノボ・ノルデイスク・エー／エス	インスリン誘導体を含有する薬学的製剤
US9150633B2 (en) *	2007-08-15	2015-10-06	Novo Nordisk A/S	Insulin analogues with an acyl and alkylene glycol moiety
RU2453332C2 (ru)	2007-10-16	2012-06-20	Байокон Лимитид	Твердая фармацевтическая композиция (варианты) и способ контроля концентрации глюкозы с ее помощью, способ получения твердой фармацевтической композиции (варианты), таблетка (варианты) и способ получения амфорных частиц
DE102008003566A1 (de) *	2008-01-09	2009-07-16	Sanofi-Aventis Deutschland Gmbh	Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
JP5695909B2 (ja) *	2008-01-09	2015-04-08	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体
MY152979A (en) *	2008-01-09	2014-12-15	Sanofi Aventis Deutschland	Novel insulin derivatives having an extremely delayed time-action profile
WO2009112583A2 (en)	2008-03-14	2009-09-17	Novo Nordisk A/S	Protease-stabilized insulin analogues
HUE032284T2 (en)	2008-03-18	2017-09-28	Novo Nordisk As	Protease-stabilized, acylated insulin analogues
US8993516B2 (en) *	2008-04-14	2015-03-31	Case Western Reserve University	Meal-time insulin analogues of enhanced stability
EP2296692A4 (en) *	2008-04-22	2012-06-06	Univ Case Western Reserve	ISOFORM-SPECIFIC INSULIN ANALOG
US9200053B2 (en)	2008-07-31	2015-12-01	Case Western Reserve University	Insulin analogues containing penta-fluoro-Phenylalanine at position B24
KR20120129875A (ko) *	2008-07-31	2012-11-28	케이스 웨스턴 리저브 유니버시티	염소화 아미노산을 갖는 인슐린 유사체
RS59913B1 (sr)	2008-10-17	2020-03-31	Sanofi Aventis Deutschland	Kombinacija insulina i glp-1-agonista
JP4959005B2 (ja)	2008-10-30	2012-06-20	ノボ・ノルデイスク・エー／エス	毎日の注射頻度より少ないインスリン注射での真性糖尿病の治療
BRPI1007457A2 (pt)	2009-01-28	2015-08-25	Smartcells Inc	Conjungado, formulação de liberação prolongada, e, sistema de distribuição de bomba.
WO2010088286A1 (en)	2009-01-28	2010-08-05	Smartcells, Inc.	Synthetic conjugates and uses thereof
US20100198188A1 (en) *	2009-02-05	2010-08-05	Abbott Diabetes Care Inc.	Devices and Methods for Metering Insoluble Active Agent Particles
US8623345B2 (en)	2009-03-20	2014-01-07	Smartcells	Terminally-functionalized conjugates and uses thereof
US20120241356A1 (en) *	2009-07-06	2012-09-27	Sanofi-Aventis Deutschland Gmbh	Heat- and vibration-stable insulin preparations
CN102596175A (zh)	2009-07-06	2012-07-18	赛诺菲-安万特德国有限公司	含有甲硫氨酸的水性胰岛素制备物
JP5675799B2 (ja) *	2009-07-06	2015-02-25	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	遅効性インスリン製剤
US8399407B2 (en) *	2009-09-17	2013-03-19	Case Western Reserve University	Non-standard insulin analogues
MY180661A (en)	2009-11-13	2020-12-04	Sanofi Aventis Deutschland	Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
PT3345593T (pt)	2009-11-13	2023-11-27	Sanofi Aventis Deutschland	Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
WO2011064316A2 (en)	2009-11-25	2011-06-03	Paolo Botti	Mucosal delivery of peptides
AU2010327949A1 (en) *	2009-12-11	2012-06-28	Case Western Reserve University	Insulin analogues with chlorinated amino acids
AU2011202239C1 (en)	2010-05-19	2017-03-16	Sanofi	Long-acting formulations of insulins
KR20130036290A (ko)	2010-06-23	2013-04-11	노보 노르디스크 에이/에스	추가 이황화 결합을 함유하는 인슐린 유도체
PL2611458T3 (pl)	2010-08-30	2017-02-28	Sanofi-Aventis Deutschland Gmbh	Zastosowanie AVE0010 do produkcji leku do leczenia cukrzycy typu 2
DK2632478T3 (da)	2010-10-27	2019-10-07	Novo Nordisk As	Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN103596584B (zh)	2011-06-15	2016-12-14	诺沃—诺迪斯克有限公司	多取代的胰岛素
AR087693A1 (es)	2011-08-29	2014-04-09	Sanofi Aventis Deutschland	Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en)	2011-09-01	2016-12-01	Sanofi Aventis Deutschland	Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CN104364260B (zh)	2012-04-11	2017-02-22	诺和诺德股份有限公司	胰岛素制剂
US9707276B2 (en)	2012-12-03	2017-07-18	Merck Sharp & Dohme Corp.	O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
TWI780236B (zh)	2013-02-04	2022-10-11	法商賽諾菲公司	胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
UA117480C2 (uk)	2013-04-03	2018-08-10	Санофі	Лікування цукрового діабету за допомогою складу інсуліну тривалої дії
EP2991672A1 (en)	2013-04-30	2016-03-09	Novo Nordisk A/S	Novel administration regime
JP6499184B2 (ja)	2013-10-07	2019-04-10	ノヴォノルディスクアー／エス	インスリン類似体の新規な誘導体
MX2016008979A (es)	2014-01-09	2016-10-04	Sanofi Sa	Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina.
MX2016008978A (es)	2014-01-09	2016-10-04	Sanofi Sa	Formulaciones farmaceuticas de analogos de insulina y/o derivados de insulina estabilizadas y que estan libres de glicerol.
BR112016015851A2 (pt)	2014-01-09	2017-08-08	Sanofi Sa	Formulações farmacêuticas estabilizadas de insulina aspart
AR099569A1 (es)	2014-02-28	2016-08-03	Novo Nordisk As	Derivados de insulina y los usos médicos de estos
KR20170069997A (ko) *	2014-08-11	2017-06-21	알바니 메디칼 칼리지	미리스토일화된 렙틴-관련된 펩티드 및 이들의 용도
BR112017004544A2 (pt)	2014-10-06	2018-01-23	Univ Case Western Reserve	insulina de cadeia simples, composição farmacêutica e método para tratar diabetes mellitus
EP3229828B1 (en)	2014-12-12	2023-04-05	Sanofi-Aventis Deutschland GmbH	Insulin glargine/lixisenatide fixed ratio formulation
CN105884879A (zh) *	2015-01-26	2016-08-24	漳州博欣生物技术有限公司	一种胰岛素类似物的化学合成方法
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
ES2908373T3 (es)	2015-08-25	2022-04-28	Novo Nordisk As	Nuevos derivados de insulina y los usos médicos de los mismos
CN105597087B (zh) *	2016-01-06	2019-04-26	山东新时代药业有限公司	一种甘精胰岛素注射液及其制备方法
EP3509625A1 (en) *	2016-09-06	2019-07-17	Chemical & Biopharmaceutical Laboratories of Patras S.A.	Proinsulin derivatives
EP3329930A1 (en)	2016-12-05	2018-06-06	Nuritas Limited	Pharmaceuctical compositions
MX388822B (es)	2016-12-05	2025-03-20	Nuritas Ltd	Composiciones que comprenden peptido wkdeagkplvk.
PE20210857A1 (es)	2016-12-16	2021-05-18	Novo Nordisk As	Composiciones farmaceuticas que contienen insulina
US20200147215A1 (en) *	2017-04-24	2020-05-14	Simon H. Friedman	Drug conjugates with photocleavable solubility modulators
JOP20190273A1 (ar) *	2017-05-26	2019-11-24	Lilly Co Eli	مركب إنسولين معالج بأسيل
US11413352B2 (en)	2017-12-18	2022-08-16	Merck, Sharp & Dohme LLC	Conjugate based systems for controlled insulin delivery
EP3727424A4 (en)	2017-12-18	2021-10-27	Merck Sharp & Dohme Corp.	CONJUGATE-BASED SYSTEMS FOR CONTROLLED INSULIN RELEASE
CN112512534A (zh) *	2018-05-14	2021-03-16	艾伊拉米治疗有限公司	用于回溶为高浓度液态溶液的胰岛素制剂
US10335464B1 (en)	2018-06-26	2019-07-02	Novo Nordisk A/S	Device for titrating basal insulin
KR20210102347A (ko)	2018-12-11	2021-08-19	사노피	인슐린 수용체 결합 친화성이 감소된 인슐린 유사체
CN110063932A (zh) *	2019-04-12	2019-07-30	浙江大学	一种多肽蛋白类药物的缓释组合物制剂及其制备方法
US12343383B2 (en)	2019-07-12	2025-07-01	Novo Nordisk A/S	High concentration insulin formulation
DK4073097T3 (da)	2019-12-11	2024-08-19	Novo Nordisk As	Nye insulinanaloger og anvendelser heraf
GB2610490A (en)	2020-03-31	2023-03-08	Protomer Tech Inc	Conjugates for selective responsiveness to vicinal diols
EP4149516A4 (en) *	2020-05-15	2024-11-13	Eli Lilly and Company	LONG-ACTING ACYLATED INSULIN COMPOUNDS
IL302775A (en)	2020-11-19	2023-07-01	Protomer Tech Inc	Aromatic boron-containing compounds and insulin analogs
EP4255469A4 (en) *	2020-12-07	2025-01-22	Case Western Reserve University	ACYLATED SINGLE-CHAIN INSULIN ANALOGUES
IL317049A (en)	2022-05-18	2025-01-01	Protomer Tech Inc	Aromatic boron-containing compounds and related insulin analogs

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2538018A (en)	1944-04-04	1951-01-16	Nordisk Insulinlab	Crystalline product of insulin and alkaline protein and process of making it
US2801953A (en)	1952-02-28	1957-08-06	Hoechst Ag	Process of preparing crystallized insulin preparations
US2849370A (en)	1953-06-04	1958-08-26	Novo Terapeutisk Labortorium A	Injectable insulin preparations with protracted effect and process of producing same
US3102077A (en)	1953-08-19	1963-08-27	Christensen Henry Marinus	Preparation of insulin containing 2.75 to 8 percent zinc content
US3060093A (en)	1957-07-18	1962-10-23	Nordisk Insulinlab	Slowly acting insulin preparation in crystalline form and method of preparation
DE1793517C3 (de)	1968-09-28	1974-12-05	Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt	N(Al),N(B29>Bis-(tert.-butyloxycarbonyl)-insulin und Verfahren zu seiner Herstellung
US3869437A (en)	1970-05-08	1975-03-04	Nat Res Dev	Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
US3950517A (en)	1970-05-08	1976-04-13	National Research Development Corporation	Insulin derivatives
GB1381274A (en)	1971-01-28	1975-01-22	Nat Res Dev	Insulin derivatives
US3868358A (en)	1971-04-30	1975-02-25	Lilly Co Eli	Protamine-insulin product
US3865325A (en)	1971-07-02	1975-02-11	Dylaker Computer Systems Inc	Flexible tape reel
US3907763A (en)	1972-03-01	1975-09-23	Bayer Ag	Insulin derivatives crosslinked by a dicarboxylic acid moiety
US4183849A (en)	1975-01-15	1980-01-15	Nordisk Insulinlaboratorium	Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect
JPS55138393A (en)	1979-04-13	1980-10-29	Shionogi & Co Ltd	Semisynthesis of insulin
JPS55138391A (en)	1979-04-13	1980-10-29	Shionogi & Co Ltd	New synthetic method of peptide derivative
IE50892B1 (en)	1980-02-11	1986-08-06	Novo Industri As	Process for preparing insulin esters
DE3101382A1 (de)	1981-01-17	1982-09-02	Hoechst Ag, 6000 Frankfurt	"verfahren zur herstellung von humanisulin oder dessen derivaten aus schweineinsulin oder dessen derivaten"
DK353781A (da)	1981-08-10	1983-02-11	Novo Industri As	Fremgangsmaade til fremstilling af insulinderivater
AU551174B2 (en)	1981-09-15	1986-04-17	Nordisk Insulinlaboratorium	Enzymatic preparation of human insulin or b-30 esters thereof
DE3326473A1 (de)	1983-07-22	1985-01-31	Hoechst Ag, 6230 Frankfurt	Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3327709A1 (de)	1983-07-29	1985-02-07	Hoechst Ag, 6230 Frankfurt	Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
US4946828A (en) *	1985-03-12	1990-08-07	Novo Nordisk A/S	Novel insulin peptides
PH25772A (en)	1985-08-30	1991-10-18	Novo Industri As	Insulin analogues, process for their preparation
JPH01254699A (ja)	1988-04-05	1989-10-11	Kodama Kk	インスリン誘導体及びその用途
JPH03506023A (ja)	1988-07-20	1991-12-26	ノボ　ノルデイスク　アクツイエセルスカプ	ポリペプチド
DE3837825A1 (de) *	1988-11-08	1990-05-10	Hoechst Ag	Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
HUT56857A (en)	1988-12-23	1991-10-28	Novo Nordisk As	Human insulin analogues
IL93282A (en)	1989-02-09	1995-08-31	Lilly Co Eli	Insulin analogues
US5514646A (en)	1989-02-09	1996-05-07	Chance; Ronald E.	Insulin analogs modified at position 29 of the B chain
DK134189D0 (da)	1989-03-20	1989-03-20	Nordisk Gentofte	Insulinforbindelser
JP2837956B2 (ja)	1993-06-21	1998-12-16	ノボノルディスクアクティーゼルスカブ	Ａｓｐ▲上Ｂ２８▼インスリン結晶
DK72793D0 (da) *	1993-06-21	1993-06-21	Novo Nordisk As	Nyt produkt
EP1132404A3 (en)	1993-09-17	2002-03-27	Novo Nordisk A/S	Acylated insulin
US5461031A (en) *	1994-06-16	1995-10-24	Eli Lilly And Company	Monomeric insulin analog formulations
US5474978A (en)	1994-06-16	1995-12-12	Eli Lilly And Company	Insulin analog formulations
US5597893A (en)	1994-10-31	1997-01-28	Eli Lilly And Company	Preparation of stable insulin analog crystals
US5646242A (en) *	1994-11-17	1997-07-08	Eli Lilly And Company	Selective acylation of epsilon-amino groups
US5693609A (en) *	1994-11-17	1997-12-02	Eli Lilly And Company	Acylated insulin analogs
CZ289343B6 (cs)	1995-03-17	2002-01-16	Novo Nordisk A/S	Inzulinový derivát a farmaceutický prostředek pro léčení diabetes
US5700904A (en) *	1995-06-07	1997-12-23	Eli Lilly And Company	Preparation of an acylated protein powder
US5877153A (en)	1996-06-11	1999-03-02	Commonwealth Biotechnologies Inc.	Heparin-binding peptides
EP0910402B1 (en)	1996-06-20	2007-08-08	Novo Nordisk A/S	Insulin preparations containing mannitol
US5948751A (en)	1996-06-20	1999-09-07	Novo Nordisk A/S	X14-mannitol
ATE294189T1 (de)	1997-02-07	2005-05-15	Novo Nordisk As	Kristallisation von proteinen
ZA989744B (en)	1997-10-31	2000-04-26	Lilly Co Eli	Method for administering acylated insulin.

1998
- 1998-10-22 JP JP2000517736A patent/JP2001521006A/ja not_active Withdrawn
- 1998-10-22 HR HR20000236A patent/HRP20000236A2/hr not_active Application Discontinuation
- 1998-10-22 WO PCT/US1998/022313 patent/WO1999021573A1/en not_active Ceased
- 1998-10-22 PL PL98340255A patent/PL340255A1/xx not_active Application Discontinuation
- 1998-10-22 JP JP2000517731A patent/JP2001521004A/ja not_active Withdrawn
- 1998-10-22 KR KR1020007004395A patent/KR20010024556A/ko not_active Ceased
- 1998-10-22 AU AU11117/99A patent/AU1111799A/en not_active Abandoned
- 1998-10-22 TR TR2000/01050T patent/TR200001050T2/xx unknown
- 1998-10-22 BR BR9813111-7A patent/BR9813111A/pt not_active IP Right Cessation
- 1998-10-22 SV SV1998000125A patent/SV1998000125A/es unknown
- 1998-10-22 HU HU0004169A patent/HUP0004169A3/hu unknown
- 1998-10-22 CO CO98061475A patent/CO4970769A1/es unknown
- 1998-10-22 CA CA002306877A patent/CA2306877A1/en not_active Abandoned
- 1998-10-22 PE PE1998000996A patent/PE123799A1/es not_active Application Discontinuation
- 1998-10-22 EP EP98953852A patent/EP1039920A4/en not_active Withdrawn
- 1998-10-22 WO PCT/US1998/022434 patent/WO1999021578A1/en not_active Ceased
- 1998-10-22 ID IDW20000748A patent/ID24890A/id unknown
- 1998-10-22 CA CA002306905A patent/CA2306905A1/en not_active Abandoned
- 1998-10-22 US US09/177,685 patent/US6268335B1/en not_active Expired - Lifetime
- 1998-10-22 CN CN98810334A patent/CN1276731A/zh active Pending
- 1998-10-22 EA EA200000453A patent/EA200000453A1/ru unknown
- 1998-10-22 IL IL13490198A patent/IL134901A0/xx unknown
- 1998-10-22 AU AU11166/99A patent/AU747926B2/en not_active Ceased
- 1998-10-22 AR ARP980105267A patent/AR020047A1/es unknown
2000
- 2000-04-18 NO NO20002038A patent/NO20002038L/no not_active Application Discontinuation
2001
- 2001-01-17 US US09/761,903 patent/US6465426B2/en not_active Expired - Fee Related
- 2001-12-06 US US10/010,038 patent/US20020082199A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PE123799A1 (es)	1999-12-13
EP1039920A4 (en)	2003-05-28
AU747926B2 (en)	2002-05-30
IL134901A0 (en)	2001-05-20
HUP0004169A3 (en)	2001-06-28
JP2001521006A (ja)	2001-11-06
US6465426B2 (en)	2002-10-15
CA2306905A1 (en)	1999-05-06
US20010036916A1 (en)	2001-11-01
CA2306877A1 (en)	1999-05-06
AU1116699A (en)	1999-05-17
NO20002038L (no)	2000-06-26
WO1999021573A1 (en)	1999-05-06
US20020082199A1 (en)	2002-06-27
US6268335B1 (en)	2001-07-31
NO20002038D0 (no)	2000-04-18
CN1276731A (zh)	2000-12-13
PL340255A1 (en)	2001-01-29
HUP0004169A2 (hu)	2001-05-28
EA200000453A1 (ru)	2000-10-30
EP1039920A1 (en)	2000-10-04
HRP20000236A2 (en)	2001-02-28
AU1111799A (en)	1999-05-17
JP2001521004A (ja)	2001-11-06
KR20010024556A (ko)	2001-03-26
BR9813111A (pt)	2000-08-15
SV1998000125A (es)	1999-05-24
TR200001050T2 (tr)	2000-08-21
CO4970769A1 (es)	2000-11-07
WO1999021578A1 (en)	1999-05-06
AR020047A1 (es)	2002-04-10

Publication	Publication Date	Title
ID24890A (id)	2000-08-31	Komposisi-komposisi insulin yang tidak dapat larut
ID22231A (id)	1999-09-23	Komposisi-komposisi yang mengandung sianoakrilat yang dapat dipulihkan dengan radiasi
ID20837A (id)	1999-03-11	Mikrokapsul dengan laju pelepasan yang mudah disesuaikan
ID26509A (id)	2001-01-11	Komponen-komponen yang mengandung tetrahidrolipstatin
ID25476A (id)	2000-10-05	Komposisi-komposisi yang tidak dapat larut untuk mengontrol glukosa darah
DE69934918D1 (de)	2007-03-08	Brennstoffzusammensetzung
DE69825475D1 (de)	2004-09-09	Injektionsmischer
PT884053E (pt)	2002-12-31	Formulacoes de insulina estaveis
ID28110A (id)	2001-05-03	Surfaktan alkilbenzenasulfonat yang disempurnakan
NO2006014I1 (no)	2006-11-13	Insulin glulisin
DE69535651D1 (de)	2008-01-03	Unverbleite treibstoffzusammensetzungen
EE200100420A (et)	2002-12-16	Kütusekoostis
ID27741A (id)	2001-04-26	Larutan teriparatide yang distabilkan
DE69832516D1 (de)	2005-12-29	Isoflavon-enthaltende zusammensetzungen
DE69836106D1 (de)	2006-11-16	Stanolester enthaltende Zusammensetzungen
DE59804498D1 (de)	2002-07-25	Kraftstoffeinspritzvorrichtung
GB9714948D0 (en)	1997-09-17	Improvements relating to injection devices
PT1139761E (pt)	2003-10-31	Composicoes herbicidas e concentrados tensioactivos
ATE283332T1 (de)	2004-12-15	Propoxilat enthaltende kraftstoffzusammensetzungen
ID26317A (id)	2000-12-14	Formulasi pelepasan yang diperpanjang
ID23809A (id)	2000-05-11	Komposisi-komposisi alginat yang dapat dituang
DE69837482D1 (de)	2007-05-16	Entschäumende zusammensetzungen
ID22174A (id)	1999-09-09	Komposisi-komposisi isosianat untuk busa poliuretana dengan rapatan yang rendah
ID25464A (id)	2000-10-05	Bahan bakar dengan penyalaan yang disempurnakan
DE69814990D1 (de)	2003-07-03	Einspritzventil